Biofields Therapy on Warts

NCT02773719 | Completed

• 1 other identifier: 15-163
• Study Type: interventional
• Target: 62
• Locations: 1 country
• Sites: 1

Brief Summary

Traditionally, healers are willing to look after, two out of three French citizens have already appealed to them at least once during their lives. Many healers in good faith are exercising their magnetism as a "gift" often inherited from elders. Now, they create interest of doctors who do not hesitate in some cases to ensure their cooperation, to implicitly recognize their mysterious talents. Some serious studies have examined these practices: Several studies have been conducted on the influence of biofield therapies in pain, depression and fatigue in cancer disease. The investigators propose a study of the effect of magnetism on the wart disease whose cure is objectively assessable. Sixty-two subjects in total would be included, comparing 2 proportions observed: the proportion of healing in the group treated with a "real" biofield therapist (recognized and affiliated to the National Group for Alternative Medicine in France) to the proportion of healing in the group treated with a "fake" biofield therapist (someone assessed as not having capacity to magnetize). The "fake" biofield therapist, placebo, has been trained to replicate gestures during a training validated by an independent recognized biofield therapist.

Conditions

Wart; Energy Medecine; Magnetism

Outcome Measures

Primary Outcomes (1)

• disappearance of a common palmar or plantar wart

  week 3

Secondary Outcomes (5)

• disappearance of each other wart than the original one 3 weeks after the therapy

  week 3

• Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3

  week3

• Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3

  week 3

• Disappearance of warts at 6 weeks

  week 6

• Level of belief in biofield therapy of the subject

  week 6

Study Arms (2)

True biofield therapist

EXPERIMENTAL

Subject will have a 40 minutes therapy with a real biofield therapist to treat the wart

Other: True Biofield therapy

Fake biofield therapist

PLACEBO COMPARATOR

Subject will have a 40 minutes therapy with a fake biofield therapist to treat the wart

Other: Fake Biofield therapy

Interventions

True Biofield therapy OTHER

True biofield therapist

Fake Biofield therapy OTHER

Fake biofield therapist

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

Patients with common warts on hands or feet for over at least 3 months are eligible for the study. Patients fulfilling one or more of the following criteria will not be included: lack of informed consent prior to randomization, younger than 18 years or under judicial protection, treated with oral corticotherapy for more than 6 months, immunosuppressed or with history of transplant surgery, undergoing chemotherapy or suspected to have carcinomatous warts, or patients with infected warts, injured warts or already treated within 90 days with chemical processing, medical device, surgery or ever treated with biofield therapy. Subject will be excluded from the study if its warts was treated by other treatment during protocol. * ulcerated wart * cancerous wart

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• University Hospital, Caen: lead

Study Sites (1)

Caen University Hospital

Caen, France

Location

Related Publications (1)

• Gaillard C, Allain L, Legros H, Brucato S, Desgue Y, Rouillon C, Peyro-Saint-Paul L, Dompmartin A. Real versus sham proximal biofield therapy in the treatment of warts of the hands and feet in adults: study protocol for a randomized controlled trial (MAGNETIK study). Trials. 2017 Jun 7;18(1):263. doi: 10.1186/s13063-017-1994-4.

  PMID: 28592299 RESULT

MeSH Terms

Conditions

Warts

Condition Hierarchy (Ancestors)

Papillomavirus Infections; DNA Virus Infections; Virus Diseases; Infections; Skin Diseases, Viral; Tumor Virus Infections; Skin Diseases, Infectious; Skin Diseases; Skin and Connective Tissue Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 22, 2016
• First Posted: May 16, 2016
• Study Start: April 1, 2016
• Primary Completion: November 1, 2018
• Study Completion: November 1, 2018
• Last Updated: April 2, 2026

Record last verified: 2016-04

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)